Press Releases & Statements (Page 5)

April 27, 2017

Alliance Thanks Senate HELP Committee for Advancing FDA Commissioner Nomination of Dr. Scott Gottlieb

Alliance for Aging Research President and CEO Susan Peschin, MHS, has issued the following statement thanking Chairman Lamar Alexander and the U.S. Senate HELP Committee for advancing the nomination of Dr. Scott Gottlieb as U.S. Food and Drug Administration (FDA) commissioner to the full Senate for a vote.
April 21, 2017

Alliance Statement in Support of the March for Science

Alliance for Aging Research (Alliance) President and CEO, Susan Peschin, MHS, has issued the following statement in support of the April 22, 2017, March for Science.
April 4, 2017

Alliance’s Bens Offers Testimony on User Fee Programs before Senate HELP Committee

Today, the Alliance for Aging Research's (Alliance) Vice President of Public Policy Cynthia Bens testifies before the U.S. Senate HELP Committee on reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA).
April 3, 2017

Alliance Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner

Alliance for Aging Research President and CEO Susan Peschin, MHS, has issued a statement in support of the nomination of Scott Gottlieb, M.D., to be commissioner of the U.S. Food and Drug Administration (FDA).
March 28, 2017

Alliance’s Bens Offers Testimony on MDUFA before House Committee

Today, the Alliance for Aging Research's Vice President of Public Policy Cynthia Bens testifed before the U.S. House of Representatives' Energy and Commerce Committee, Subcommittee on Health, in regard to reauthorization of the Medical Device User Fee Act (MDUFA).
March 22, 2017

Statement on Congressional Action to Reauthorize the FDA’s Prescription Drug and Medical Device User Fee Programs

Alliance for Aging Research Vice President of Public Policy Cynthia Bens issued the following statement regarding congressional action taken this week to begin consideration of the U.S. Food and Drug Administration’s (FDA) prescription drug and medical device user fee programs.
March 16, 2017

Alliance for Aging Research Statement on President Trump’s FY 2018 Budget Blueprint

Alliance for Aging Research (Alliance) President and CEO Susan Peschin, MHS, has issued a statement in response to President Trump’s fiscal year (FY) 2018 Budget Blueprint released today:
March 10, 2017

Alliance for Aging Research, Relevate Health Group Partner to Raise Awareness about Deep Vein Thrombosis, Venous Thromboembolism

The Alliance for Aging Research is partnering with Relevate Health Group® to raise awareness about deep vein thrombosis (DVT) and venous thromboembolism (VTE) in honor of Deep Vein Thrombosis Awareness Month in March and World Thrombosis Day on October 13.
March 9, 2017

Alliance for Aging Research Statement on The American Health Care Act

Alliance for Aging Research (Alliance) President and CEO Susan Peschin, MHS, has issued a statement regarding the markup of the American Health Care Act by the Committee on Ways and Means and the Energy and Commerce Committee in the U.S. House of Representatives.
February 22, 2017

First-Ever Heart Valve Disease Awareness Day Puts Condition in National Spotlight

The first-ever National Heart Valve Disease Awareness Day is being celebrated throughout the country today, as organizations, advocates, and individuals join together to increase recognition about the risks of heart valve disease (HVD) and improve detection and treatment access to ultimately save lives.